Modular Medical (MODD) announced the appointment of David Bosshard as Head of International Operations. With two decades of expertise in scaling similar tubeless insulin delivery systems across Europe and beyond, Mr. Bosshard will drive Modular Medical’s global strategy, leveraging his success in launching blockbuster products, such as Insulet’s Omnipod and Ypsomed’s YpsoPump, to position the Company for international growth in the rapidly expanding wearable diabetes technology sector.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MODD:
- Modular Medical announces exercise of warrants for $4.4M in proceeds
- Modular Medical Announces Strategic Warrant Exercise Agreement
- Modular Medical receives IRB approval for Pivot system feasability study
- Modular Medical completes MODD1 pump study
- Modular Medical completes MODD1 cartridge production